---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-24-000195"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2024-12-17T23:59:59+00:00"
generated_at: "2026-05-29T02:39:12.108111+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pfizer provides 2025 revenue guidance $61-64B, adj. EPS $2.80-3.00

## Summary
- Full-year 2025 revenue guidance range of $61.0 to $64.0 billion, with operational growth approximately flat to 5% year-over-year.
- Full-year 2025 adjusted diluted EPS guidance range of $2.80 to $3.00, reflecting operational growth of 10% to 18%.
- Achieved goal of $4.0 billion in net cost savings through 2024; expects an additional $500 million in savings in 2025.
- First phase of manufacturing optimization program on track to deliver initial net cost savings in latter part of 2025.
- Reaffirmed full-year 2024 guidance: revenue $61-64B, adjusted EPS $2.75-2.95.

## SEC filing metadata
- accession: 0000078003-24-000195
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2024-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800324000195/0000078003-24-000195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800324000195/pfe-20241217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-24-000195
- JSON: https://secwatch.observer/filing/0000078003-24-000195.json
- Plain text: https://secwatch.observer/filing/0000078003-24-000195.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.